3.59
Outset Medical Inc stock is traded at $3.59, with a volume of 82,236.
It is up +0.70% in the last 24 hours and down -31.23% over the past month.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
See More
Previous Close:
$3.565
Open:
$3.57
24h Volume:
82,236
Relative Volume:
0.40
Market Cap:
$67.48M
Revenue:
$117.59M
Net Income/Loss:
$-74.85M
P/E Ratio:
-0.8599
EPS:
-4.175
Net Cash Flow:
$-34.25M
1W Performance:
-8.88%
1M Performance:
-31.23%
6M Performance:
+1.70%
1Y Performance:
-73.11%
Outset Medical Inc Stock (OM) Company Profile
Name
Outset Medical Inc
Sector
Industry
Phone
669-231-8200
Address
3052 ORCHARD DRIVE, SAN JOSE
Compare OM vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
OM
Outset Medical Inc
|
3.59 | 80.83M | 117.59M | -74.85M | -34.25M | -4.175 |
|
ABT
Abbott Laboratories
|
108.33 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
94.17 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
303.13 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
47.80 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.90 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jun-21-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-08-24 | Initiated | BTIG Research | Buy |
| Apr-05-24 | Upgrade | CL King | Neutral → Buy |
| Jan-12-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-17-23 | Initiated | CL King | Neutral |
| Nov-11-22 | Initiated | RBC Capital Mkts | Outperform |
| Jul-14-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-17-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-18-21 | Initiated | Cowen | Outperform |
| Apr-19-21 | Initiated | Wells Fargo | Overweight |
| Dec-16-20 | Initiated | Oppenheimer | Perform |
| Oct-12-20 | Initiated | Barclays | Overweight |
| Oct-12-20 | Initiated | BofA Securities | Buy |
| Oct-12-20 | Initiated | Goldman | Buy |
| Oct-12-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-12-20 | Initiated | SVB Leerink | Mkt Perform |
| Oct-12-20 | Initiated | Stifel | Buy |
View All
Outset Medical Inc Stock (OM) Latest News
Outset Medical (OM) Q2 2026 Earnings Call Transcript - AOL.com
Outset (OM) Results at a Glance: Reported EPS Misses Expectations at the Close; Session Move: The Stock Ends Down 1.05% in the Latest ReadingEarnings Manipulation Risk - vinanet.vn
Outset Medical CEO Leslie Trigg sells $15,088 in shares By Investing.com - Investing.com Australia
Outset Medical CEO Leslie Trigg sells $15,088 in shares - Investing.com
Leslie Trigg Sells 3,437 Shares of Outset Medical (NASDAQ:OM) Stock - MarketBeat
Outset Medical general counsel sells $11,554 in stock By Investing.com - Investing.com Canada
Outset Medical general counsel sells $11,554 in stock - Investing.com
Outset Medical Earnings Call Highlights Refresh Tailwinds - TipRanks
Outset Medical CFO Renee Gaeta sells $19,943 in stock By Investing.com - Investing.com Australia
Outset Medical CFO Renee Gaeta sells $19,943 in stock - Investing.com
Outset Medical (NASDAQ:OM) CFO Renee Gaeta Sells 4,543 Shares of Stock - MarketBeat
Outset Medical (OM) counsel sells shares to cover taxes - Stock Titan
OM Q2 2026 Earnings: EPS Misses Estimates as Loss Per Share WidensEarnings Risk Report - Vinanet
Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock - Yahoo Finance
Outset Medical (NASDAQ:OM) Raised to Hold at Wall Street Zen - MarketBeat
OM (OM) insider schedules potential sale of 4,422 shares after RSU vesting - Stock Titan
Outset Medical (OM) insider Leslie Trigg plans NASDAQ sale of 3,344 shares - Stock Titan
Outset Medical (OM) insider files to sell shares and settle RSUs - Stock Titan
OM Q2 2026 Earnings: Wider-than-Expected Loss Sends Shares Down 5.6%Earnings Miss Streak - vinanet.vn
OM Q2 2026 Earnings: Wider Loss Per Share Sends Stock Down 6.6%Earnings Per Share - vinanet.vn
Outset Medical, Inc. (NASDAQ:OM) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Bank of America (OM) reports 3.5% beneficial stake in Outset Medical shares - Stock Titan
AQR Capital discloses 5.39% Outset Medical (OM) ownership in Schedule 13G - Stock Titan
RBC Capital Initiates Outset Medical(OM.US) With Hold Rating, Announces Target Price $7 - Moomoo
Outset Medical Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Outset Medical (NASDAQ:OM) Issues Quarterly Earnings Results - marketbeat.com
Outset Medical 2Q Rev $31.6M >OM - Moomoo
Is Outset Medical Inc (OM) Meeting Investor Expectations with Q2 - GuruFocus
OM Looks 24.4% Overvalued on GF Value™ - GuruFocus
OM Looks 24.4% Overvalued on GF Value™ as Market Prices in Growt - GuruFocus
Outset Medical Inc (OM) (Q2 2026) Earnings Call Highlights: Reve - GuruFocus
Outset Medical Q2 Earnings Call Highlights - MarketBeat
Outset Medical Inc (OM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Strategic HCA ... - Yahoo Finance
Outset Medical earnings missed by $0.05, revenue topped estimates - Investing.com Canada
Outset Medical (OM) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Earnings call transcript: Outset Medical posts mixed Q2 2026 results, shares edge up - Investing.com
Outset Medical, Inc. Q2 2026: Revenue $31.6M, EPS $(0.97) — 10-Q Summary - TradingView
[10-Q] Outset Medical, Inc. Quarterly Earnings Report - Stock Titan
Outset Medical, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Q2 2026 Outset Medical Inc Earnings Call Transcript - GuruFocus
Outset Medical Q2 adjusted loss per share narrows less than expected - TradingView
Outset Medical Reports Second Quarter 2026 Results - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Outset Medical reports Q2 revenue $31.6M, gross margin 42%, reiterates 2026 guidance - TradingView
BRIEF-Outset Medical Q2 Net Income USD -17.984 Million - TradingView
Outset Medical (OM) Rallies 1.95% as Shares Hold Above $4.96 SupportLong Setup Ideas - vinanet.vn
Earnings To Watch: Outset Medical Inc (OM) Q2 2026 -- GF Value S - GuruFocus
Earnings To Watch: Outset Medical Inc (OM) Q2 2026 -- GF Value Sees 12% Downside - Yahoo Finance
Outset Medical Market Sentiment - Benzinga España
Outset Medical, Inc. expected to post a loss of 72 cents a shareEarnings Preview - TradingView
Outset Medical Inc Stock (OM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Outset Medical Inc Stock (OM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Brottem John L. | General Counsel |
Aug 17 '26 |
Sale |
4.39 |
2,632 |
11,554 |
87,475 |
| Gaeta Renee | Chief Financial Officer |
Aug 17 '26 |
Sale |
4.39 |
4,543 |
19,944 |
180,840 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):